Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The APRE-PONV Trial
NCT06357234Phase 2Recruiting
- Sponsor
- IWK Health
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by IWK Health. Started Mar 2025; status: recruiting.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06357234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06357234.